Platelet transfusion refractoriness

British Journal of Haematology

Volumn 142, Issue 3, 2008, Pages 348-360

  Hod, Eldad ^b   Schwartz, Joseph ^a,b  

^a New York Presbyterian Hospital Weill Cornell Medical Campus   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Alloimmunization; Corrected count increment; HLA compatible; Platelet refractoriness; Platelet transfusion

Indexed keywords

AMOXICILLIN; AMPHOTERICIN; AMPICILLIN; BLEOMYCIN; CEPHALOSPORIN; CIMETIDINE; CIPROFLOXACIN; CYCLOSPORIN A; DICLOFENAC; FAMOTIDINE; FENTANYL; FLUDARABINE; IBUPROFEN; LEVOFLOXACIN; LINEZOLID; METRONIDAZOLE; NAFCILLIN; NAPROXEN; OXALIPLATIN; PARACETAMOL; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RANITIDINE; RIFAMPICIN; RITUXIMAB; SALICYLIC ACID; SULFANILAMIDE; THROMBOCYTE ANTIGEN; UNINDEXED DRUG; VANCOMYCIN;

ALLOIMMUNIZATION; ANTIBODY SPECIFICITY; BLOOD BANK; BLOOD GROUP ABO SYSTEM; BLOOD GROUP TYPING; CLINICAL ASSESSMENT; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; PLATELET REFRACTORINESS; PRIORITY JOURNAL; REFRACTION INDEX; REVIEW; SEPSIS; SPLENOMEGALY; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT INDICATION; VEIN OCCLUSION;

BLOOD GROUPING AND CROSSMATCHING; BLOOD PLATELETS; HLA ANTIGENS; HUMANS; ISOANTIBODIES; PLATELET COUNT; PLATELET TRANSFUSION; SEPSIS; THROMBOCYTOPENIA; TREATMENT FAILURE;

EID: 46949103859     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07189.x     Document Type: Review

References (115)

1. Abbas, M.M., Berka, N., Bobo, L.D. Dunston, G.M. (2004) DNA yield from buccal swabs and its utilization in HLA typing using luminex SSO bead technology. Human Immunology, 65, S81.
2. Allen, D., Ouwehand, W.H., de Haas, M., Kekomaki, R., Kaplan, C. Metcalfe, P. (2007) Interlaboratory variation in the detection of HPA-specific alloantibodies and in molecular HPA typing. Vox Sanguinis, 93, 316 324.
3. Anasetti, C., Doney, K.C., Storb, R., Meyers, J.D., Farewell, V.T., Buckner, C.D., Appelbaum, F.R., Sullivan, K.M., Clift, R.A., Deeg, H.J., Fefer, A., Martin, P.J., Singer, J.W., Sanders, J.E., Stewart, P.S., Witherspoon, R.P. Thomas, E.D. (1986) Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. Annals of Internal Medicine, 104, 461 466.
4. Anasetti, C., Rybka, W., Sullivan, K.M., Banaji, M. Slichter, S.J. (1989) Graft-v-host disease is associated with autoimmune-like thrombocytopenia. Blood, 73, 1054 1058.
5. Andonegui, G., Kerfoot, S.M., McNagny, K., Ebbert, K.V., Patel, K.D. Kubes, P. (2005) Platelets express functional Toll-like receptor-4. Blood, 106, 2417 2423.
6. Aslam, R., Speck, E.R., Kim, M., Crow, A.R., Bang, K.W., Nestel, F.P., Ni, H., Lazarus, A.H., Freedman, J. Semple, J.W. (2006) Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood, 107, 637 641.
7. Aster, R.H. (1965) Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood, 26, 732 743.
8. Aster, R.H. (1966) Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. Journal of Clinical Investigation, 45, 645 657.
9. Aster, R.H. Bougie, D.W. (2007) Drug-induced immune thrombocytopenia. New England Journal of Medicine, 357, 580 587.
10. Bayer, W.L., Bodensteiner, D.C., Tilzer, L.L. Adams, M.E. (1992) Use of platelets and other transfusion products in patients with malignancy. Seminars in Thrombosis and Hemostasis, 18, 380 391.
11. Bernstein, S.H., Nademanee, A.P., Vose, J.M., Tricot, G., Fay, J.W., Negrin, R.S., DiPersio, J., Rondon, G., Champlin, R., Barnett, M.J., Cornetta, K., Herzig, G.P., Vaughan, W., Geils, Jr, G., Keating, A., Messner, H., Wolff, S.N., Miller, K.B., Linker, C., Cairo, M., Hellmann, S., Ashby, M., Stryker, S. Nash, R.A. (1998) A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood, 91, 3509 3517.
12. Bessos, H., Atkinson, A., McGill, A., Baillie, J., Seghatchian, J., Vickers, M., Bishop, D., Tandy, N. Murphy, W.G. (1996) Apheresis platelet concentrates: correlation of day one levels of in vitro quality markers with corresponding levels on days two to five of storage. Thrombosis Research, 84, 367 372.
13. Bishop, J.F., McGrath, K., Wolf, M.M., Matthews, J.P., De Luise, T., Holdsworth, R., Yuen, K., Veale, M., Whiteside, M.G., Cooper, I.A. Szer, J. (1988) Clinical factors influencing the efficacy of pooled platelet transfusions. Blood, 71, 383 387.
14. Bishop, J.F., Matthews, J.P., McGrath, K., Yuen, K., Wolf, M.M. Szer, J. (1991) Factors influencing 20-hour increments after platelet transfusion. Transfusion, 31, 392 396.
15. Bolgiano, D.C., Larson, E.B. Slichter, S.J. (1989) A model to determine required pool size for HLA-typed community donor apheresis programs. Transfusion, 29, 306 310.
16. Brand, A., Claas, F.H., Voogt, P.J., Wasser, M.N. Eernisse, J.G. (1988) Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Vox Sanguinis, 54, 160 166.
17. Brubaker, D.B., Marcus, C. Holmes, E. (1998) Intravascular and total body platelet equilibrium in healthy volunteers and in thrombocytopenic patients transfused with single donor platelets. American Journal of Hematology, 58, 165 176.
18. Christie, D.J., Howe, R.B., Lennon, S.S. Sauro, S.C. (1993) Treatment of refractoriness to platelet transfusion by protein A column therapy. Transfusion, 33, 234 242.
19. Claas, F.H., Smeenk, R.J., Schmidt, R., van Steenbrugge, G.J. Eernisse, J.G. (1981) Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Experimental Hematology, 9, 84 89.
20. Daly, P.A., Schiffer, C.A., Aisner, J. Wiernik, P.H. (1980) Platelet transfusion therapy. One-hour posttransfusion increments are valuable in predicting the need for HLA-matched preparations. JAMA, 243, 435 438.
21. Daly, A.S., Hasegawa, W.S., Lipton, J.H., Messner, H.A. Kiss, T.L. (2002) Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver. Transfusion and Apheresis Science, 27, 3 12.
22. Datema, G., Stein, S., Eijsink, C., Mulder, A., Claas, F.H. Doxiadis, I.I. (2000) HLA-C expression on platelets: studies with an HLA-Cw1-specific human monoclonal antibody. Vox Sanguinis, 79, 108 111.
23. Davis, R.B., Meeker, W.R. Mc, Q.D. (1960) Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets. Circulation Research, 8, 234 239.
24. Doughty, H.A., Murphy, M.F., Metcalfe, P., Rohatiner, A.Z., Lister, T.A. Waters, A.H. (1994) Relative importance of immune and non-immune causes of platelet refractoriness. Vox Sanguinis, 66, 200 205.
25. Dunstan, R.A., Simpson, M.B., Knowles, R.W. Rosse, W.F. (1985) The origin of ABH antigens on human platelets. Blood, 65, 615 619.
26. Duquesnoy, R.J. (2008) Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion, 48, 221 227.
27. Duquesnoy, R.J., Anderson, A.J., Tomasulo, P.A. Aster, R.H. (1979) ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients. Blood, 54, 595 599.
28. Dutcher, J.P., Schiffer, C.A., Aisner, J. Wiernik, P.H. (1981) Alloimmunization following platelet transfusion: the absence of a dose-response relationship. Blood, 57, 395 398.
29. Elzey, B.D., Tian, J., Jensen, R.J., Swanson, A.K., Lees, J.R., Lentz, S.R., Stein, C.S., Nieswandt, B., Wang, Y., Davidson, B.L. Ratliff, T.L. (2003) Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity, 19, 9 19.
30. Fontao-Wendel, R., Silva, L.C., Saviolo, C.B., Primavera, B. Wendel, S. (2007) Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assays for the detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sanguinis, 93, 241 249.
31. Francois, B., Trimoreau, F., Vignon, P., Fixe, P., Praloran, V. Gastinne, H. (1997) Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. American Journal of Medicine, 103, 114 120.
32. Friedberg, R.C., Donnelly, S.F., Boyd, J.C., Gray, L.S. Mintz, P.D. (1993) Clinical and blood bank factors in the management of platelet refractoriness and alloimmunization. Blood, 81, 3428 3434.
33. Godeau, B., Fromont, P., Seror, T., Duedari, N. Bierling, P. (1992) Platelet alloimmunization after multiple transfusions: a prospective study of 50 patients. British Journal of Haematology, 81, 395 400.
34. Grishaber, J.E., Birney, S.M. Strauss, R.G. (1993) Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens. Transfusion, 33, 910 914.
35. Hanson, S.R. Slichter, S.J. (1985) Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood, 66, 1105 1109.
36. Heal, J.M., Blumberg, N. Masel, D. (1987) An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients. Blood, 70, 23 30.
37. Heddle, N.M., Klama, L., Kelton, J.G., Meyer, R., Walker, I., Dickson, L., Chambers, S. Levine, M.N. (1995) The use of anti-D to improve post-transfusion platelet response: a randomized trial. British Journal of Haematology, 89, 163 168.
38. Heffner, J.E. (1997) Platelet-neutrophil interactions in sepsis - platelet guilt by association? Intensive Care Medicine, 23, 366 368.
39. Heuer, L. Blumenberg, D. (2005) Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets. Blood Coagulation and Fibrinolysis, 16, 287 290.
40. Hill-Zobel, R.L., McCandless, B., Kang, S.A., Chikkappa, G. Tsan, M.F. (1986) Organ distribution and fate of human platelets: studies of asplenic and splenomegalic patients. American Journal of Hematology, 23, 231 238.
41. Hoffman, R. (2005) Hematology: Basic Principles and Practice. Elsevier Churchill Livingstone, Edinburgh.
42. Hogge, D.E., Dutcher, J.P., Aisner, J. Schiffer, C.A. (1984) The ineffectiveness of random donor platelet transfusion in splenectomized, alloimmunized recipients. Blood, 64, 253 256.
43. Ishida, A., Handa, M., Wakui, M., Okamoto, S., Kamakura, M. Ikeda, Y. (1998) Clinical factors influencing posttransfusion platelet increment in patients undergoing hematopoietic progenitor cell transplantation - a prospective analysis. Transfusion, 38, 839 847.
44. Jones, R.J., Lee, K.S., Beschorner, W.E., Vogel, V.G., Grochow, L.B., Braine, H.G., Vogelsang, G.B., Sensenbrenner, L.L., Santos, G.W. Saral, R. (1987) Venoocclusive disease of the liver following bone marrow transplantation. Transplantation, 44, 778 783.
45. Kalmadi, S., Tiu, R., Lowe, C., Jin, T. Kalaycio, M. (2006) Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. Cancer, 107, 136 140.
46. Kickler, T.S., Braine, H. Ness, P.M. (1985) The predictive value of crossmatching platelet transfusion for alloimmunized patients. Transfusion, 25, 385 389.
47. Kickler, T., Kennedy, S.D. Braine, H.G. (1990a) Alloimmunization to platelet-specific antigens on glycoproteins IIb-IIIa and Ib/IX in multiply transfused thrombocytopenic patients. Transfusion, 30, 622 625.
48. Kickler, T., Braine, H.G., Piantadosi, S., Ness, P.M., Herman, J.H. Rothko, K. (1990b) A randomized, placebo-controlled trial of intravenous gammaglobulin in alloimmunized thrombocytopenic patients. Blood, 75, 313 316.
49. Kiefel, V., Santoso, S., Weisheit, M. Mueller-Eckhardt, C. (1987) Monoclonal antibody - specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood, 70, 1722 1726.
50. Kiefel, V., Konig, C., Kroll, H. Santoso, S. (2001) Platelet alloantibodies in transfused patients. Transfusion, 41, 766 770.
51. Klingemann, H.G., Self, S., Banaji, M., Deeg, H.J., Doney, K., Slichter, S.J., Thomas, E.D. Storb, R. (1987) Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases. British Journal of Haematology, 66, 115 121.
52. Klumpp, T.R., Herman, J.H., Gaughan, J.P., Russo, R.R., Christman, R.A., Goldberg, S.L., Ackerman, S.J., Bleecker, G.C. Mangan, K.F. (1999) Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion, 39, 674 681.
53. Kurz, M., Knobl, P., Kalhs, P., Greinix, H.T., Hocker, P. Panzer, S. (2001) Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test. Transfusion, 41, 771 774.
54. Lalezari, P. Driscoll, A.M. (1982) Ability of thrombocytes to acquire HLA specificity from plasma. Blood, 59, 167 170.
55. Laundy, G.J., Bradley, B.A., Rees, B.M., Younie, M. Hows, J.M. (2004) Incidence and specificity of HLA antibodies in multitransfused patients with acquired aplastic anemia. Transfusion, 44, 814 825.
56. Lee, E.J. Schiffer, C.A. (1989) ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial. Transfusion, 29, 384 389.
57. Legler, T.J., Fischer, I., Dittmann, J., Simson, G., Lynen, R., Humpe, A., Riggert, J., Schleyer, E., Kern, W., Hiddemann, W. Kohler, M. (1997) Frequency and causes of refractoriness in multiply transfused patients. Annals of Hematology, 74, 185 189.
58. Levin, M.D., de Veld, J.C., van der Holt, B. van't Veer, M.B. (2003) Screening for alloantibodies in the serum of patients receiving platelet transfusions: a comparison of the ELISA, lymphocytotoxicity, and the indirect immunofluorescence method. Transfusion, 43, 72 77.
59. Levin, M.D., van der Holt, B., de Veld, J.C., Gratama, J.W., de Vries, W. van't Veer, M.B. (2004) The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients. Vox Sanguinis, 87, 291 298.
60. Lubenko, A., Rodi, K.M. Johnson, A.C. (2001) Screening for WBC antibodies by lymphocyte indirect immunofluorescence flow cytometry: superior to cytotoxicity and ELISA? Transfusion, 41, 1147 1153.
61. McFarland, J.G., Anderson, A.J. Slichter, S.J. (1989) Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. British Journal of Haematology, 73, 380 386.
62. McGrath, K., Wolf, M., Bishop, J., Veale, M., Ayberk, H., Szer, J., Cooper, I. Whiteside, M. (1988) Transient platelet and HLA antibody formation in multitransfused patients with malignancy. British Journal of Haematology, 68, 345 350.
63. van der Meer, P.F. Pietersz, R.N. (2005) Gamma irradiation does not affect 7-day storage of platelet concentrates. Vox Sanguinis, 89, 97 99.
64. Menitove, J.E. Duquesnoy, R.J. (1981) Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients. American Journal of Medical Technology, 47, 114 120.
65. Moroff, G., Garratty, G., Heal, J.M., MacPherson, B.R., Stroncek, D., Huang, S.T., Ho, W., Petz, L.D., Leach, M.F., Lennon, S.S., Rowe, J.M., Saleh, M.N., Arndt, P., Foley, K., Masel, D. Postoway, N. (1992) Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion, 32, 633 640.
66. Murphy, M.F., Metcalfe, P., Thomas, H., Eve, J., Ord, J., Lister, T.A. Waters, A.H. (1986) Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization. British Journal of Haematology, 62, 529 534.
67. Murphy, M.F., Metcalfe, P., Ord, J., Lister, T.A. Waters, A.H. (1987) Disappearance of HLA and platelet-specific antibodies in acute leukaemia patients alloimmunized by multiple transfusions. British Journal of Haematology, 67, 255 260.
68. Myers, T.J., Kim, B.K., Steiner, M. Baldini, M.G. (1981) Selection of donor platelets for alloimmunized patients using a platelet-associated IgG assay. Blood, 58, 444 450.
69. Nagasawa, T., Kim, B.K. Baldini, M.G. (1978) Temporary suppression of circulating antiplatelet alloantibodies by the massive infusion of fresh, stored, or lyophilized platelets. Transfusion, 18, 429 435.
70. Nambiar, A., Duquesnoy, R.J., Adams, S., Zhao, Y., Oblitas, J., Leitman, S., Stroncek, D. Marincola, F. (2006) HLAmatchmaker-driven analysis of responses to HLA-typed platelet transfusions in alloimmunized thrombocytopenic patients. Blood, 107, 1680 1687.
71. Narvios, A., Reddy, V., Martinez, F. Lichtiger, B. (2005) Slow infusion of platelets: a possible alternative in the management of refractory thrombocytopenic patients. American Journal of Hematology, 79, 80.
72. Neame, P.B., Kelton, J.G., Walker, I.R., Stewart, I.O., Nossel, H.L. Hirsh, J. (1980) Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood, 56, 88 92.
73. Nijsten, M.W., ten Duis, H.J., Zijlstra, J.G., Porte, R.J., Zwaveling, J.H., Paling, J.C. The, T.H. (2000) Blunted rise in platelet count in critically ill patients is associated with worse outcome. Critical Care Medicine, 28, 3843 3846.
74. Nordhagen, R. Flaathen, S.T. (1985) Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test. Vox Sanguinis, 48, 156 159.
75. Norol, F., Kuentz, M., Cordonnier, C., Beaujean, F., Haioun, C., Vernant, J.P. Duedari, N. (1994) Influence of clinical status on the efficiency of stored platelet transfusion. British Journal of Haematology, 86, 125 129.
76. O'Connell, B., Lee, E.J. Schiffer, C.A. (1988) The value of 10-minute posttransfusion platelet counts. Transfusion, 28, 66 67.
77. O'Connell, B.A., Lee, E.J., Rothko, K., Hussein, M.A. Schiffer, C.A. (1992) Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood, 79, 527 531.
78. Pappalardo, P.A., Secord, A.R., Quitevis, P., Haimowitz, M.D. Goldfinger, D. (2001) Platelet transfusion refractoriness associated with HPA-1a (Pl(A1)) alloantibody without coexistent HLA antibodies successfully treated with antigen-negative platelet transfusions. Transfusion, 41, 984 987.
79. Pei, R., Lee, J.H., Shih, N.J., Chen, M. Terasaki, P.I. (2003) Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation, 75, 43 49.
80. Petz, L.D., Garratty, G., Calhoun, L., Clark, B.D., Terasaki, P.I., Gresens, C., Gornbein, J.A., Landaw, E.M., Smith, R. Cecka, J.M. (2000) Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion, 40, 1446 1456.
81. Phekoo, K.J., Hambley, H., Schey, S.A., Win, N., Carr, R. Murphy, M.F. (1997) Audit of practice in platelet refractoriness. Vox Sanguinis, 73, 81 86.
82. Pitchford, S.C., Momi, S., Giannini, S., Casali, L., Spina, D., Page, C.P. Gresele, P. (2005) Platelet P-selectin is required for pulmonary eosinophil and lymphocyte recruitment in a murine model of allergic inflammation. Blood, 105, 2074 2081.
83. Rachel, J.M., Summers, T.C., Sinor, L.T. Plapp, F.V. (1988) Use of a solid phase red blood cell adherence method for pretransfusion platelet compatibility testing. American Journal of Clinical Pathology, 90, 63 68.
84. Ratko, T.A., Burnett, D.A., Foulke, G.E., Matuszewski, K.A. Sacher, R.A. (1995) Recommendations for off-label use of intravenously administered immunoglobulin preparations University Hospital Consortium Expert Panel for Off-Label Use of Polyvalent Intravenously Administered Immunoglobulin Preparations. JAMA, 273, 1865 1870.
85. Read, E.J., Kodis, C., Carter, C.S. Leitman, S.F. (1988) Viability of platelets following storage in the irradiated state. A pair-controlled study. Transfusion, 28, 446 450.
86. Rebulla, P. (1993) Formulae for the definition of refractoriness to platelet transfusion. Transfusion Medicine, 3, 91 93.
87. Rebulla, P., Morelati, F., Revelli, N., Villa, M.A., Paccapelo, C., Nocco, A., Greppi, N., Marconi, M., Cortelezzi, A., Fracchiolla, N., Martinelli, G. Deliliers, G.L. (2004) Outcomes of an automated procedure for the selection of effective platelets for patients refractory to random donors based on cross-matching locally available platelet products. British Journal of Haematology, 125, 83 89.
88. Rio, B., Andreu, G., Nicod, A., Arrago, J.P., Dutrillaux, F., Samama, M. Zittoun, R. (1986) Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy. Blood, 67, 1773 1776.
89. Rozman, P. (2002) Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transplant Immunology, 10, 165 181.
90. Sacher, R.A., Kickler, T.S., Schiffer, C.A., Sherman, L.A., Bracey, A.W. Shulman, I.A. (2003) Management of patients refractory to platelet transfusion. Archives of Pathology and Laboratory Medicine, 127, 409 414.
91. Saito, S., Ota, S., Seshimo, H., Yamazaki, Y., Nomura, S., Ito, T., Miki, J., Ota, M., Fukushima, H. Maeda, H. (2002) Platelet transfusion refractoriness caused by a mismatch in HLA-C antigens. Transfusion, 42, 302 308.
92. Santoso, S., Kalb, R., Kiefel, V. Mueller-Eckhardt, C. (1993) The presence of messenger RNA for HLA class I in human platelets and its capability for protein biosynthesis. British Journal of Haematology, 84, 451 456.
93. Sayeh, E., Sterling, K., Speck, E., Freedman, J. Semple, J.W. (2004) IgG antiplatelet immunity is dependent on an early innate natural killer cell-derived interferon-gamma response that is regulated by CD8+ T cells. Blood, 103, 2705 2709.
94. Schiffer, C.A., Lichtenfeld, J.L., Wiernik, P.H., Mardiney, Jr, M.R. Joseph, J.M. (1976) Antibody response in patients with acute nonlymphocytic leukemia. Cancer, 37, 2177 2182.
95. Schiffer, C.A., O'Connell, B. Lee, E.J. (1989) Platelet transfusion therapy for alloimmunized patients: selective mismatching for HLA B12, an antigen with variable expression on platelets. Blood, 74, 1172 1176.
96. Schiffer, C.A., Anderson, K.C., Bennett, C.L., Bernstein, S., Elting, L.S., Goldsmith, M., Goldstein, M., Hume, H., McCullough, J.J., McIntyre, R.E., Powell, B.L., Rainey, J.M., Rowley, S.D., Rebulla, P., Troner, M.B. Wagnon, A.H. (2001) Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. Journal of Clinical Oncology, 19, 1519 1538.
97. Semple, J.W., Speck, E.R., Milev, Y.P., Blanchette, V. Freedman, J. (1995) Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation. Blood, 86, 805 812.
98. Semple, J.W., Aslam, R., Kim, M., Speck, E.R. Freedman, J. (2007) Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood, 109, 4803 4805.
99. Sigurdsson, G.H., Christenson, J.T., el-Rakshy, M.B. Sadek, S. (1992) Intestinal platelet trapping after traumatic and septic shock. An early sign of sepsis and multiorgan failure in critically ill patients? Critical Care Medicine, 20, 458 467.
100. Slichter, S.J. (1997) Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. New England Journal of Medicine, 337, 1861 1869.
101. Slichter, S.J., Davis, K., Enright, H., Braine, H., Gernsheimer, T., Kao, K.J., Kickler, T., Lee, E., McFarland, J., McCullough, J., Rodey, G., Schiffer, C.A. Woodson, R. (2005) Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood, 105, 4106 4114.
102. Sniecinski, I., O'Donnell, M.R., Nowicki, B. Hill, L.R. (1988) Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood, 71, 1402 1407.
103. Stephan, F., Cheffi, M.A., Kaplan, C., Maillet, J., Novara, A., Fagon, J. Bonnet, F. (2000) Autoantibodies against platelet glycoproteins in critically ill patients with thrombocytopenia. American Journal of Medicine, 108, 554 560.
104. Storb, R., Prentice, R.L., Buckner, C.D., Clift, R.A., Appelbaum, F., Deeg, J., Doney, K., Hansen, J.A., Mason, M., Sanders, J.E., Singer, J., Sullivan, K.M., Witherspoon, R.P. Thomas, E.D. (1983) Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. New England Journal of Medicine, 308, 302 307.
105. Tinmouth, A.T., Semple, E., Shehata, N. Branch, D.R. (2006) Platelet immunopathology and therapy: a Canadian Blood Services Research and Development Symposium. Transfusion Medicine Reviews, 20, 294 314.
106. Vanderschueren, S., De Weerdt, A., Malbrain, M., Vankersschaever, D., Frans, E., Wilmer, A. Bobbaers, H. (2000) Thrombocytopenia and prognosis in intensive care. Critical Care Medicine, 28, 1871 1876.
107. Visentin, G.P., Wolfmeyer, K., Newman, P.J. Aster, R.H. (1990) Detection of drug-dependent, platelet-reactive antibodies by antigen-capture ELISA and flow cytometry. Transfusion, 30, 694 700.
108. Warkentin, T.E., Aird, W.C. Rand, J.H. (2003) Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology American Society of Hematology. Education Program Book, 497 519.
109. van de Watering, L., Hermans, J., Witvliet, M., Versteegh, M. Brand, A. (2003) HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: a randomized controlled trial. Transfusion, 43, 765 771.
110. Wu, Y.Y. Csako, G. (2006) Rapid and/or high-throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications. Clinica Chimica Acta, 363, 165 176.
111. Yang, J., Furie, B.C. Furie, B. (1999) The biology of P-selectin glycoprotein ligand-1: its role as a selectin counterreceptor in leukocyte-endothelial and leukocyte-platelet interaction. Thrombosis and Haemostasis, 81, 1 7.
112. Yankee, R.A., Graff, K.S., Dowling, R. Henderson, E.S. (1973) Selection of unrelated compatible platelet donors by lymphocyte HL-A matching. New England Journal of Medicine, 288, 760 764.
113. Zachary, A.A., Klingman, L., Thorne, N., Smerglia, A.R. Teresi, G.A. (1995) Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation, 60, 498 503.
114. Zarbock, A., Singbartl, K. Ley, K. (2006) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. Journal of Clinical Investigation, 116, 3211 3219.
115. Zarbock, A., Polanowska-Grabowska, R.K. Ley, K. (2007) Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Reviews, 21, 99 111.